MedTrace Logo

Evolutive Potential of Embryos Obtained From Oocytes After Luteal Phase Ovarian Stimulation

NCT01645241 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2014-10-27

No results posted yet for this study

Summary

The purpose of this study is to evaluate the clinical pregnancy rate per embryo transfer in oocytes recipients obtained after ovarian stimulation during the luteal phase of oocytes donors . This study will be performed in egg recipients and donors but this type of treatment is meant to be implemented in fertility preservation patients

Conditions

  • INFERTILITY
  • Fertility Preservation
  • Ovulation Induction
  • Vitrification
  • Oocyte Donation

Interventions

DRUG

gonadotropins plus GnRH antagonists

DRUG

ganirelix

Sponsors & Collaborators

  • FUNDACION DEXEUS SALUT DE LA DONA

    collaborator UNKNOWN

  • Ayudas Merck Serono de Investigación 2012

    collaborator UNKNOWN

  • Fundacion Dexeus

    lead OTHER

Principal Investigators

  • Francisca Martínez, PhD · Fundación Dexeus Salut de la Dona

Study Design

Allocation
NA
Purpose
TREATMENT
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
35 Years
Sex
FEMALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-07-31
Primary Completion
2013-12-31
Completion
2013-12-31

Countries

  • Spain

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01645241 on ClinicalTrials.gov